Oxford Biomedica PLC
06 June 2005
Oxford BioMedica plc ('the Company')
Directors' Interest in Shares and Share Options
Oxford BioMedica (OXB:L) The Company today announced that Peter Nolan and Andrew
Wood, both directors of the Company, have exercised options over 153,470 and
176,799 1p ordinary shares respectively.
The options which have been exercised were granted on 24 September 1998, and if
not exercised, would otherwise lapse on 24 September 2005. Peter Nolan and
Andrew Wood have sold today 93,512 and 107,727 shares respectively at 32.0 pence
per share, this being the amount necessary to fund the exercise of the options
and the associated tax liability. The remaining shares, 59,958 and 69,072
respectively, have been retained, increasing both directors' holdings of 1p
ordinary shares.
The total interests of Peter Nolan and Andrew Wood in the Company's 1p ordinary
shares and share options following these transactions are:
Shares Share options
Peter Nolan 147,738 730,028
Andrew Wood 198,022 1,065,891
The exercise price for the options exercised today was 11p per share. The newly
allotted shares are subject to a block listing, so are already listed. Including
these shares, the total number of the Company's issued 1p ordinary shares is now
375,540,162.
Andrew Wood
Company Secretary, Oxford BioMedica plc
6 June 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.